Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Xuehui Jiang, Qun Fu, Yan Jing, Ying Kong, Hong Liu, Hongwei Peng, Kaisaner Rexiti & Xiaohua Wei. (2023) Personalized Dose of Adjuvant Imatinib in Patients with Gastrointestinal Stromal Tumors: Results from a Population Pharmacokinetic Analysis. Drug Design, Development and Therapy 17, pages 809-820.
Read now
Read now
Gloria Ravegnini, Giorgia Valori, Qianqian Zhang, Riccardo Ricci, Patrizia Hrelia & Sabrina Angelini. (2020) Pharmacogenetics in the treatment of gastrointestinal stromal tumors – an updated review. Expert Opinion on Drug Metabolism & Toxicology 16:9, pages 797-808.
Read now
Read now
Gloria Ravegnini, César Serrano, Vittorio Simeon, Giulia Sammarini, Margherita Nannini, Erica Roversi, Milena Urbini, Fabrizio Ferrè, Riccardo Ricci, Giuseppe Tarantino, Maria A. Pantaleo, Patrizia Hrelia & Sabrina Angelini. (2019) The rs17084733 variant in the KIT 3’ UTR disrupts a miR-221/222 binding site in gastrointestinal stromal tumour: a sponge-like mechanism conferring disease susceptibility. Epigenetics 14:6, pages 545-557.
Read now
Read now
Fulvio Massaro, Gioia Colafigli, Matteo Molica & Massimo Breccia. (2018) Novel tyrosine-kinase inhibitors for the treatment of chronic myeloid leukemia: safety and efficacy. Expert Review of Hematology 11:4, pages 301-306.
Read now
Read now
Gloria Ravegnini, Giulia Sammarini, Margherita Nannini, Maria A. Pantaleo, Guido Biasco, Patrizia Hrelia & Sabrina Angelini. (2017) Gastrointestinal stromal tumors (GIST): Facing cell death between autophagy and apoptosis. Autophagy 13:3, pages 452-463.
Read now
Read now
Andrew Rowland, Madelé van Dyk, Arduino A. Mangoni, John O. Miners, Ross A. McKinnon, Michael D. Wiese, Angela Rowland, Ganessan Kichenadasse, Howard Gurney & Michael J. Sorich. (2017) Kinase inhibitor pharmacokinetics: comprehensive summary and roadmap for addressing inter-individual variability in exposure. Expert Opinion on Drug Metabolism & Toxicology 13:1, pages 31-49.
Read now
Read now
Articles from other publishers (17)
Maddalena Centanni, Abel Thijs, Ingrid Desar, Mats O. Karlsson & Lena E. Friberg. (2022) Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine‐kinase inhibitors. Clinical and Translational Science 16:1, pages 73-84.
Crossref
Crossref
Raquel Alves, Ana Cristina Gonçalves, Joana Jorge, Gilberto Marques, André B. Ribeiro, Rita Tenreiro, Margarida Coucelo, Joana Diamond, Bárbara Oliveiros, Amélia Pereira, Paulo Freitas-Tavares, António M. Almeida & Ana Bela Sarmento-Ribeiro. (2022) Genetic Variants of ABC and SLC Transporter Genes and Chronic Myeloid Leukaemia: Impact on Susceptibility and Prognosis. International Journal of Molecular Sciences 23:17, pages 9815.
Crossref
Crossref
Keiko Maekawa, Masahiro Yamamura, Atsushi Matsuki, Takashi Ishikawa, Toshihiro Hirai, Yoshiyuki Yamaguchi, Yoshiro Saito & Tatsuo Kanda. (2022) Impacts of SNPs on adverse events and trough concentration of imatinib in patients with gastrointestinal stromal tumors. Drug Metabolism and Pharmacokinetics 43, pages 100441.
Crossref
Crossref
Yan Li, Baohui Yang & Xingwang Zhang. (2019) Oral delivery of imatinib through galactosylated polymeric nanoparticles to explore the contribution of a saccharide ligand to absorption. International Journal of Pharmaceutics 568, pages 118508.
Crossref
Crossref
Gloria Ravegnini, Milena Urbini, Vittorio Simeon, Chiara Genovese, Annalisa Astolfi, Margherita Nannini, Lidia Gatto, Maristella Saponara, Manuela Ianni, Valentina Indio, Giovanni Brandi, Stefania Trino, Patrizia Hrelia, Guido Biasco, Sabrina Angelini & Maria A. Pantaleo. (2018) An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor. The Pharmacogenomics Journal 19:4, pages 390-400.
Crossref
Crossref
Qing Wang, Zhi-Ping Jiang, Er-Qian Yu, Jing Zeng, Yan Zhu, Hua-Lin Cai, Miao Yan, Da-Xiong Xiang, Xie-Lan Zhao, Ping Xu, Zheng Jiao & Hoan Linh Banh. (2019) Population pharmacokinetic and pharmacogenetics of imatinib in Chinese patients with chronic myeloid leukemia. Pharmacogenomics 20:4, pages 251-260.
Crossref
Crossref
Gloria Ravegnini, Giulia Sammarini, César Serrano, Margherita Nannini, Maria A. Pantaleo, Patrizia Hrelia & Sabrina Angelini. (2019) Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors. Therapeutic Advances in Medical Oncology 11, pages 175883591983190.
Crossref
Crossref
Margherita Nannini & Guido Biasco. 2019. Oncogenomics. Oncogenomics
329
337
.
Qiang Zhang, Jianghao Xu, Yi Qian, Liang Chen, Qingya Li, Kangjing Xu, Ming Chen, Luning Sun, Zhongyuan He, Li Yang, Diancai Zhang, Linjun Wang, Xiaofeng Sun, Yongqing Wang, Hao Xu & Zekuan Xu. (2018) Association of Imatinib Plasma Concentration and Single-nucleotide Polymorphisms with Adverse Drug Reactions in Patients with Gastrointestinal Stromal Tumors. Molecular Cancer Therapeutics 17:12, pages 2780-2787.
Crossref
Crossref
H-B Qiu, W Zhuang, T Wu, S Xin, C-Z Lin, H-L Ruan, X Zhu, M Huang, J-L Li, X-Y Hou, Z-W Zhou & X-D Wang. (2017) Imatinib-induced ophthalmological side-effects in GIST patients are associated with the variations of EGFR, SLC22A1, SLC22A5 and ABCB1. The Pharmacogenomics Journal 18:3, pages 460-466.
Crossref
Crossref
Sarah Cargnin, Gloria Ravegnini, Simona Soverini, Sabrina Angelini & Salvatore Terrazzino. (2018) Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysis. Pharmacological Research 131, pages 244-254.
Crossref
Crossref
Michiel C. Verboom, Jacqueline S.L. Kloth, Jesse J. Swen, Tahar van der Straaten, Judith V.M.G. Bovée, Stefan Sleijfer, Anna K.L. Reyners, Ron H.J. Mathijssen, Henk-Jan Guchelaar, Neeltje Steeghs & Hans Gelderblom. (2017) Genetic polymorphisms in angiogenesis-related genes are associated with worse progression-free survival of patients with advanced gastrointestinal stromal tumours treated with imatinib. European Journal of Cancer 86, pages 226-232.
Crossref
Crossref
Natarajan Harivenkatesh, Lalit Kumar, Sameer Bakhshi, Atul Sharma, Madhulika Kabra, Thirumurthy Velpandian, Ajay Gogia, Shivaram S. Shastri, Nihar Ranjan Biswas & Yogendra Kumar Gupta. (2017) Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemia. Pharmacological Research 120, pages 138-145.
Crossref
Crossref
Gloria Ravegnini, Margherita Nannini, Corrado Zenesini, Vittorio Simeon, Giulia Sammarini, Milena Urbini, Lidia Gatto, Maristella Saponara, Guido Biasco, Maria A. Pantaleo, Nicola Venturoli, Patrizia Hrelia & Sabrina Angelini. (2016) An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure. Angiogenesis 20:1, pages 139-148.
Crossref
Crossref
Zhi-Ping Jiang, Xie-Lan Zhao, Naoto Takahashi, Sabrina Angelini, Biswajit Dubashi, Li Sun & Ping Xu. (2017)
Trough concentration and
ABCG2
polymorphism are better to predict imatinib response in chronic myeloid leukemia: a meta-analysis
. Pharmacogenomics 18:1, pages 35-56.
Crossref
Crossref
Maria Abbondanza Pantaleo, Gloria Ravegnini, Annalisa Astolfi, Vittorio Simeon, Margherita Nannini, Maristella Saponara, Milena Urbini, Lidia Gatto, Valentina Indio, Giulia Sammarini, Donatella Santini, Manuela Ferracin, Massimo Negrini, Patrizia Hrelia, Guido Biasco & Sabrina Angelini. (2016) Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors. Epigenomics 8:10, pages 1347-1366.
Crossref
Crossref
Gloria Ravegnini, Margherita Nannini, Vittorio Simeon, Muriel Musti, Giulia Sammarini, Maristella Saponara, Lidia Gatto, Milena Urbini, Annalisa Astolfi, Guido Biasco, Maria A. Pantaleo, Nicola Venturoli, Patrizia Hrelia & Sabrina Angelini. (2016) Polymorphisms in DNA repair genes in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome. Tumor Biology 37:10, pages 13413-13423.
Crossref
Crossref